ESC 365 - The incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit

ESC Premium Access

The incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit

Session: Novelties in atrial fibrillation and flutter management

Topic: Epidemiology, Prognosis, Outcome

Speaker: Mrs M. Jacobs (Groningen, NL)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Mrs Maartje Jacobs

University Medical Centre Groningen, Groningen (Netherlands (The))

0 follower

5 more presentations in this session

Typical atrial flutter is a manifestation of previously silent coronary artery disease

Speaker: Mr L. Iden (Bad Segeberg, DE)

Pericardial fat volume outperforms classic risk markers in the prediction of relapse after pulmonary vein isolation

Speaker: Doctor J. Carmo (Carnaxide, PT)

Zero-fluoroscopy catheter ablation of right- and left-sided supraventricular tachycardias

Speaker: Doctor M. Jan (Ljubljana, SI)

Doxapram is a promising new antiarrhythmic drug for an atrial-specific therapy of atrial fibrillation

Speaker: Doctor C. Schmidt (Heidelberg, DE)

Pulsed Field Ablation: Acute and Chronic Safety and Lesion Efficacy

Speaker: Doctor A. Verma (Montreal, CA)

Access the full session

Novelties in atrial fibrillation and flutter management

Speakers: Mrs M. Jacobs, Mr L. Iden, Doctor J. Carmo, Doctor M. Jan, Doctor C. Schmidt...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources